CN116555263A - Method for constructing sgRNA combination of new soybean variety and cultivating new soybean variety and application - Google Patents
Method for constructing sgRNA combination of new soybean variety and cultivating new soybean variety and application Download PDFInfo
- Publication number
- CN116555263A CN116555263A CN202310504665.5A CN202310504665A CN116555263A CN 116555263 A CN116555263 A CN 116555263A CN 202310504665 A CN202310504665 A CN 202310504665A CN 116555263 A CN116555263 A CN 116555263A
- Authority
- CN
- China
- Prior art keywords
- sgrna
- seq
- expression vector
- soybean
- gmfad2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000068988 Glycine max Species 0.000 title claims abstract description 79
- 235000010469 Glycine max Nutrition 0.000 title claims abstract description 78
- 238000000034 method Methods 0.000 title claims abstract description 37
- 108091027544 Subgenomic mRNA Proteins 0.000 title claims abstract description 18
- 108091033409 CRISPR Proteins 0.000 claims abstract description 37
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 20
- 238000010354 CRISPR gene editing Methods 0.000 claims abstract description 18
- 239000005642 Oleic acid Substances 0.000 claims abstract description 14
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims abstract description 12
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims abstract description 12
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims abstract description 12
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims abstract description 12
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims abstract description 12
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims abstract description 12
- 238000005516 engineering process Methods 0.000 claims abstract description 7
- 238000009395 breeding Methods 0.000 claims abstract description 5
- 230000001488 breeding effect Effects 0.000 claims abstract description 5
- 239000013604 expression vector Substances 0.000 claims description 34
- 238000011144 upstream manufacturing Methods 0.000 claims description 19
- 241000589158 Agrobacterium Species 0.000 claims description 16
- 241000196324 Embryophyta Species 0.000 claims description 13
- 238000012216 screening Methods 0.000 claims description 10
- 238000012163 sequencing technique Methods 0.000 claims description 8
- 238000012408 PCR amplification Methods 0.000 claims description 6
- 238000010367 cloning Methods 0.000 claims description 6
- 229930027917 kanamycin Natural products 0.000 claims description 3
- 229960000318 kanamycin Drugs 0.000 claims description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 3
- 229930182823 kanamycin A Natural products 0.000 claims description 3
- 239000000463 material Substances 0.000 abstract description 35
- 102000003820 Lipoxygenases Human genes 0.000 abstract description 13
- 108090000128 Lipoxygenases Proteins 0.000 abstract description 13
- 238000010362 genome editing Methods 0.000 abstract description 11
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 238000003306 harvesting Methods 0.000 abstract description 2
- 230000035772 mutation Effects 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- 102000004190 Enzymes Human genes 0.000 description 27
- 108090000790 Enzymes Proteins 0.000 description 27
- 230000000694 effects Effects 0.000 description 24
- 239000000243 solution Substances 0.000 description 16
- 238000001962 electrophoresis Methods 0.000 description 15
- 239000000499 gel Substances 0.000 description 15
- 101150106914 LOX1 gene Proteins 0.000 description 14
- 101150014436 LOX1.1 gene Proteins 0.000 description 14
- 101150086211 OLR1 gene Proteins 0.000 description 14
- 102100025386 Oxidized low-density lipoprotein receptor 1 Human genes 0.000 description 14
- 101100455173 Phaseolus vulgaris LOXA gene Proteins 0.000 description 14
- 101100182222 Solanum tuberosum LOX1.2 gene Proteins 0.000 description 14
- 239000012153 distilled water Substances 0.000 description 13
- 239000007788 liquid Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 101100128612 Glycine max LOX1.2 gene Proteins 0.000 description 10
- 101150046318 LOX2 gene Proteins 0.000 description 10
- 101100343701 Mus musculus Loxl1 gene Proteins 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000013598 vector Substances 0.000 description 10
- 108010044467 Isoenzymes Proteins 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 101100128617 Arabidopsis thaliana LOX3 gene Proteins 0.000 description 7
- 101100455162 Arabidopsis thaliana LOX4 gene Proteins 0.000 description 7
- 101100455161 Glycine max LOX1.3 gene Proteins 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229910021642 ultra pure water Inorganic materials 0.000 description 6
- 239000012498 ultrapure water Substances 0.000 description 6
- 238000012795 verification Methods 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000003292 glue Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 239000012064 sodium phosphate buffer Substances 0.000 description 4
- 235000012424 soybean oil Nutrition 0.000 description 4
- 239000003549 soybean oil Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- WYPBVHPKMJYUEO-NBTZWHCOSA-M sodium;(9z,12z)-octadeca-9,12-dienoate Chemical compound [Na+].CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O WYPBVHPKMJYUEO-NBTZWHCOSA-M 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 101100446350 Glycine max FAD2-2 gene Proteins 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 229960000907 methylthioninium chloride Drugs 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 2
- -1 unsaturated fatty acid hydroperoxides Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 108700026181 Arabidopsis FAD2 Proteins 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 101150058769 FAD2 gene Proteins 0.000 description 1
- 101100446349 Glycine max FAD2-1 gene Proteins 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 101000877236 Siganus canaliculatus Acyl-CoA Delta-4 desaturase Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003225 biodiesel Substances 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019581 fat taste sensations Nutrition 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical group OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 239000001046 green dye Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000010813 internal standard method Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000008117 seed development Effects 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000010692 trans-unsaturated fatty acids Nutrition 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to the technical field of genetic engineering, and provides a sgRNA combination for constructing a new soybean variety, a method for cultivating the new soybean variety and application thereof. The sgRNA combination comprises sgRNA-GmLOX1, sgRNA-GmLOX2, sgRNA-GmLOX3 and sgRNA-GmFAD2-1A/B. According to the invention, the CRISPR/Cas9 gene editing technology is utilized to knock out the genes of soybean GmLOX1, gmLOX2, gmLOX3, gmFAD2-1A and GmFAD2-1B, so that the soybean editing material with high oleic acid content and low lipoxygenase content is obtained. And developing molecular markers according to the mutation site information to rapidly and accurately identify the mutation material. The editing material can be used as soybean material or variety suitable for mechanized harvesting, and provides valuable gene resources, germplasm resources and resource identification methods for soybean breeding.
Description
Technical Field
The invention relates to the technical field of genetic engineering, in particular to a sgRNA combination for constructing a new soybean variety, a method for cultivating the new soybean variety and application thereof.
Background
Soybean (Glycine max l.) is an important food crop that provides quality protein and vegetable oil for humans. Soybean oil plays an important role in common vegetable oils, the quality of which is mainly determined by the fatty acid composition, and generally soybean contains 13% palmitic acid, 4% stearic acid, 20% oleic acid, 55% linoleic acid and 8% linolenic acid. The increased content of oleic acid increases the shelf life of soybean oil and reduces the need for hydrogenation reactions which increase the cost of the pressing process and produce unnecessary trans-fats that further affect human health (aschorio A, willett W C.health effects of trans fatty acids [ J ]. Am J Clin Nutr,1997, 66:1006-1010.). In addition, in the production of biodiesel, oils with high oleic acid content and low saturated fatty acid content are required to improve oxidation stability and increase cold flow. The increased oxidative stability of soybean oils with high oleic acid content also opens up a variety of food and industrial applications such as spray oils and machine lubricants (Butzen S, schnebly S.high-temperature oil soy bean. Crop instruments [ J ],2007,17 (7): 3). There is also a special flavor in the ripened soybeans, which limits the development and application of soybean products. The flavor is mainly that Lipoxygenase (LOXs) catalyzes the oxidation of unsaturated fatty acids such as linoleic acid and linolenic acid to produce volatile compounds that are converted from conjugated unsaturated fatty acid hydroperoxides. In the food processing industry, beany flavors in soy products (oils, soymilk, etc.) are usually removed by heating, microwave processing, and organic solvent extraction, etc., but also add to the cost of production and processing (branch AR. Lipoxygenases: electrical, functions, catalysis, and acquisition of substrate [ J ]. J. Biol Chem,1999, 274:23679-23682). The cultivation of the soybean variety with wide adaptability and high oleic acid and without lipoxygenase is a very effective strategy, can radically solve the problem, eliminates the flavor of the soybean and improves the quality of the soybean oil under the condition of not losing the cost.
The structure and expression of the soybean FAD2 gene family at the genomic level have been previously identified. Among FAD2 genes identified in soybean, FAD2-2 desaturases include FAD2-2A (Glyma 19g 32930), FAD2-2B (Glyma 19g 32940) and FAD2-2C (Glyma 03g 30070), and FAD2-2 desaturases are widely expressed in the vegetative tissues of soybean plants. FAD2-2A is an exception, the expression is not detected, and the FAD2-2A coding region is deleted by 100bp and is predicted to be nonfunctional. Two microsomal FAD2-1 desaturases FAD2-1A (Glyma 10g 42470) and FAD2-1B (Glyma 20g 24530) were expressed predominantly in developing seeds (Okuley J, lightner J, feldmann K, yadav N, lark E, browse J.Arabidopsis FAD2 gene encodes The enzyme that is essential for polyunsaturated li pid synthesis [ J ]. The Plant cell,1994, 6:147-158). FAD2-1A and FAD2-1B are therefore believed to play an important role in controlling oleic acid levels during soybean seed development.
Mature soybean seeds mainly contain three lipoxygenase isoenzymes LOX1, LOX2 and LOX3, encoding glyma 13g347600 (GmLOX 1), glyma 13g347500 (GmLOX 2) and glyma 15g026300 (GmLOX 3), respectively. These isozymes are involved in the formation of bean flavor, LOX2 being the predominant isozyme. Natural or artificial mutants of single, double, and triple lipoxygenase isozymes have been identified and a range of soybean varieties lacking lipoxygenase have been developed using these mutant lines. In the selection of lipoxygenase-free soybean varieties, backcrossing or selfing and several rounds of selection are usually required, which is a time-consuming and laborious process (Bai M, yuan J, kuang H, gong P, li S, zhang Z, liu B, sun J, yang M, yang L, wang D, song S, guan Y.generation ofa multiplex mutagenesis population via pooled CRISPR-Cas9 in soyabean [ J ]. Plant Biotechno J,2020,18 (3): 721-731).
CRISPR/Cas9 is used as a latest gene editing technology, and RNA guides Cas9 protein nuclease to cut and modify a targeted genome at a specific site, so that gene knockout, insertion, replacement and chromosome recombination are realized. As an important tool for researching gene functions in reverse genetics, the gene has the characteristics of simple vector construction, high targeting specificity and the like. And the mutants created by using CRISPR/Cas9 gene editing technology can be used for removing vectors through selfing propagation, and the mutants with removed vectors are expected to be used for plant production.
Disclosure of Invention
The invention aims to provide a method for constructing sgRNA combination of a new soybean variety and cultivating the new soybean variety and application thereof, wherein the method can obtain a soybean editing material with high oleic acid content and low lipoxygenase content, and provides precious gene resources, germplasm resources and resource identification methods for soybean breeding.
In order to achieve the above object, the present invention provides the following technical solutions:
the invention provides an sgRNA combination for constructing a new soybean variety, which comprises sgRNA-GmLOX1, sgRNA-GmLOX2, sgRNA-GmLOX3 and sgRNA-GmFAD2-1A/B, wherein the sequence of the sgRNA-GmLOX1 is shown as SEQ ID NO.1, the sequence of the sgRNA-GmLOX2 is shown as SEQ ID NO.2, the sequence of the sgRNA-GmLOX3 is shown as SEQ ID NO.3, and the sequence of the sgRNA-GmFAD2-1A/B is shown as SEQ ID NO. 4.
The invention provides an expression vector combination for CRISPR/Cas9 editing, which comprises a first expression vector and a second expression vector;
the first expression vector is obtained by cloning the sgRNA-GmLOX1, sgRNA-GmLOX2, sgRNA-GmLOX3 of claim 1 onto the initial expression vector pBSE 401; the second expression vector was obtained by cloning sgRNA-GmFAD2-1A/B onto the initial expression vector pBSE 401.
The invention provides a method for constructing a new soybean variety by using a CRISPR/Cas9 technology, which comprises the following steps:
the first expression vector and the second expression vector are transformed into agrobacterium, soybeans are infected by agrobacterium, and new soybean varieties with GmLOX1, gmLOX2, gmLOX3, gmFAD2-1A and GmFAD2-1B genes deleted are obtained through screening.
Preferably, the agrobacterium comprises agrobacterium EHA105.
Preferably, the soybean-infested portion is a soybean cotyledonary node.
Preferably, the method of selection comprises kanamycin resistance selection and PCR amplification and sequencing of positive plants.
The invention provides application of the sgRNA combination, the CRISPR/Cas9 editing expression vector combination and the method for constructing new soybean varieties in cultivation of high-oleic acid soybean germplasm.
The invention provides application of the sgRNA combination, the CRISPR/Cas9 editing expression vector combination and the method for constructing new soybean varieties in cultivation of soybean germplasm without beany flavor.
The invention also provides a primer group for identifying the new soybean variety, which comprises primers for detecting a GmLOX1 locus, a GmLOX2 locus and a GmLOX3 locus;
the upstream and downstream primer sequences of the GmLOX1 locus are shown in SEQ ID NO.5 and SEQ ID NO. 6;
the upstream and downstream primer sequences for detecting the GmLOX2 locus are shown in SEQ ID NO.7 and SEQ ID NO. 8;
the upstream and downstream primer sequences for detecting the GmLOX3 locus are shown as SEQ ID NO.9 and SEQ ID NO. 10.
Compared with the prior art, the invention has the beneficial effects that:
according to the multi-gene editing excellent soybean material based on CRISPR/Cas9, the CRISPR/Cas9 gene editing technology is utilized to knock out the genes of soybean GmLOX1, gmLOX2, gmLOX3, gmFAD2-1A and GmFAD2-1B, so that the soybean editing material with high oleic acid content and low lipoxygenase content is obtained. The editing material can be used as soybean material or variety suitable for mechanized harvesting, and provides valuable gene resources and germplasm resources for soybean breeding.
Drawings
FIG. 1 is a view of the position of an editing site on a gene;
FIG. 2 is a schematic diagram of a CRISPR/Cas9 gene editing vector structure;
FIG. 3 is a diagram of PCR screening and identification of soybean mutant materials;
FIG. 4 shows the DNA sequencing results of the editing material in the target site region;
FIG. 5 shows the results of the assay for the LOX1 enzyme activity of the editing material; wherein A shows the color reaction result of each sample; b shows the absorbance of each sample; CK (water) represents ultrapure water, WT represents medium ji 602 having LOX1 enzyme activity; WT is colorless, while CK (water) and Y1 appear blue, indicating that Y1 does not contain LOX1 enzyme activity;
FIG. 6 shows the results of the assay for the LOX2 enzyme activity of the editing material; wherein A shows the color reaction result of each sample; b shows the absorbance of each sample; CK (water) represents ultrapure water, WT represents medium ji 602 having LOX1 enzyme activity; WT is colorless, while CK (water) and Y1 show yellow color, indicating that Y1 does not contain LOX2 enzyme activity;
FIG. 7 shows the results of the assay for the LOX3 enzyme activity of the editing material; wherein A shows the color reaction result of each sample; b shows the absorbance of each sample; CK (water) represents ultrapure water, WT represents medium ji 602 having LOX1 enzyme activity; WT is colorless, while CK (water) and Y1 appear blue, indicating that Y1 does not contain LOX3 enzyme activity;
FIG. 8 is an identification result of the Lox isozymes of the editing material;
FIG. 9 is an edit material fatty acid detection result;
FIG. 10 shows the results of rapid identification of edited material using molecular markers.
Detailed Description
The invention provides a sgRNA combination for constructing new soybean varieties, which comprises sgRNA-GmLOX1, sgRNA-GmLOX2, sgRNA-GmLOX3 and sgRNA-GmFAD2-1A/B.
In the present invention, the sgRNA-GmLOX1 is designed according to the first exon of the GmLOX1 gene, the sgRNA-GmLOX2 is designed according to the first exon of the GmLOX2 gene, the sgRNA-GmLOX3 is designed according to the first exon of the GmLOX3 gene, and the sgRNA-GmFAD2-1A/B is designed according to the first exon of the GmFAD2-1A gene and the second exon of the GmFAD2-1B gene. The position diagram of the GmLOX1, gmLOX2, gmLOX3 and GmFAD2-1A, gmFAD2-1B editing sites on the genes is shown in FIG. 1. The sequences of the above-mentioned sgRNA-GmLOX1, sgRNA-GmLOX2, sgRNA-GmLOX3 and sgRNA-GmFAD2-1A/B are as follows:
sgRNA-GmLOX1(SEQ ID NO.1):5’-TTCAGCTCATTAGTGCTACC-3’;
sgRNA-GmLOX2(SEQ ID NO.2):5’-CAACGTTGTTGGCTCAACA C-3’;
sgRNA-GmLOX3(SEQ ID NO.3):5’-GGTCAAGGTCTCGACTTAGT-3’;
sgRNA-GmFAD2-1A/B(SEQ ID NO.4):5’-CATTGCATGGCCAATCT ATT-3’。
the invention provides an expression vector combination for CRISPR/Cas9 editing, which comprises a first expression vector and a second expression vector;
the first expression vector is obtained by cloning the above sgRNA-GmLOX1, sgRNA-GmLOX2 and sgRNA-GmLOX3 onto an initial expression vector pBSE 401; the second expression vector was obtained by cloning the abovementioned sgRNA-GmFAD2-1A/B onto the initial expression vector pBSE 401.
The invention provides a method for constructing a new soybean variety by using a CRISPR/Cas9 technology, which comprises the following steps:
the first expression vector and the second expression vector are transformed into agrobacterium, soybeans are infected by agrobacterium, and new soybean varieties with GmLOX1, gmLOX2, gmLOX3, gmFAD2-1A and GmFAD2-1B genes deleted are obtained through screening.
In the present invention, the agrobacterium includes agrobacterium EHA105.
In the invention, the soybean-infected part is a soybean cotyledon section.
In the present invention, the screening method comprises kanamycin resistance screening and positive plant PCR amplification and sequencing.
In the invention, the primer sequences used for PCR amplification of the positive plants are as follows:
upstream primer GmLOX1-F of sgRNA-GmLOX1 (SEQ ID NO. 11): 5'-TAC CCATGATAGCTTTGGTTG-3';
downstream primer GmLOX1-R of sgRNA-GmLOX1 (SEQ ID NO. 12): 5'-CCC AAAGTTGGTAACGAAGTAT-3';
upstream primer GmLOX2-F of sgRNA-GmLOX2 (SEQ ID NO. 13): 5'-GTT TTCAGTTCCAGGGGTG-3';
downstream primer GmLOX2-R of sgRNA-GmLOX2 (SEQ ID NO. 14): 5'-CAT TAGAGACGGACAAATGAAC-3';
upstream primer GmLOX3-F of sgRNA-GmLOX3 (SEQ ID NO. 15): 5'-GTT GGTGGGTTGCAAAGATGCTTG-3';
downstream primer GmLOX3-R of sgRNA-GmLOX3 (SEQ ID NO. 16): 5'-GGA GGACACGCGTCATGATTA-3';
upstream primer GmFAD2-1A-F of sgRNA-GmFAD2-1A (SEQ ID NO. 17): 5'-CAGCAAAACAACTGAAACTCAAC-3';
downstream primer GmFAD2-1A-R of sgRNA-GmFAD2-1A (SEQ ID NO. 18): 5'-CAGGGTTGCAACACGGTAGA-3';
upstream primer GmFAD2-1B-F of sgRNA-GmFAD2-1B (SEQ ID NO. 19): 5'-TCTAATCTGTCACTTCCCTCCATTC-3';
downstream primer GmFAD2-1B-R of sgRNA-GmFAD2-1B (SEQ ID NO. 20): 5'-ATAGCAGCCAAACCAACCCT-3'.
The invention provides application of the sgRNA combination, the CRISPR/Cas9 editing expression vector combination and the method for constructing new soybean varieties in cultivation of high-oleic acid soybean germplasm.
The invention provides application of the sgRNA combination, the CRISPR/Cas9 editing expression vector combination and the method for constructing new soybean varieties in cultivation of soybean germplasm without beany flavor.
The invention also provides a primer group for identifying the new soybean variety, which comprises primers for detecting a GmLOX1 locus, a GmLOX2 locus and a GmLOX3 locus;
the sequence of the primer upstream and downstream of the GmLOX1 locus is shown as follows:
upstream primer (SEQ ID NO. 5): GTTGATGCCCAAGAATGAGT;
downstream primer (SEQ ID NO. 6): AAAAGTGAAACGATGAAGAA.
The sequence of the upstream and downstream primers for detecting GmLOX2 locus is as follows:
upstream primer (SEQ ID NO. 7): TTACTAAAGGAAATGTTGGGGGAC;
downstream primer (SEQ ID NO. 8): GTGTTATTGATTATGTGGAAGGAAG.
The sequence of the primer upstream and downstream of the GmLOX3 locus is shown as follows:
upstream primer (SEQ ID NO. 9): GACGTGAATAGCGTAACCAG;
downstream primer (SEQ ID NO. 10): GCCCAAGAAGGCAGTAAGAG.
The technical solutions provided by the present invention are described in detail below with reference to examples, but they should not be construed as limiting the scope of the present invention.
EXAMPLE 1 construction of Multi-Gene editing vector
Construction of sgRNA combinations from the soybean GmLOX1, gmLOX2, gmLOX3, gmFAD2-1A and GmFAD2-1B genes: sgRNA-GmLOX1 (SEQ ID NO. 1), sgRNA-GmLOX2 (SEQ ID NO. 2), sgRNA-GmLOX3 (SEQ ID NO. 3) and sgRNA-GmFAD2-1A/B (SEQ ID NO. 4). The pBSE401 vector (purchased from Tianjin Ji Nuowo Biotechnology Co., ltd.) was used as the initial expression vector, and sgRNA-GmLOX1, sgRNA-GmLOX2 and sgRNA-GmLOX3 were constructed on one vector, and sgRNA-GmFAD2-1A/B was constructed on the other vector, and two edited vectors obtained by the construction were shown in FIG. 2.
EXAMPLE 2 Stable transformation of soybeans
Two editing vectors prepared in example 1 were transformed into Agrobacterium EHA105 competent cells by: competent Agrobacterium EHA105 cells (purchased from Beijing Optimuno technologies Co., ltd.) were removed from-80℃and rapidly inserted into ice for 5min, after which the pellet was thawed, the two carriers of example 1 were added and the EP tube bottom was hand-pulled, gently mixed, and left to stand in ice for 30min; placing into liquid nitrogen for 2min, and rapidly placing into a water bath at 37deg.C for 5min. Adding 400 mu L of sterile LB culture medium without antibiotics into the centrifuge tube, uniformly mixing, and recovering for 4 hours at 28 ℃ by a 180rpm shaking table; mu.L of the supernatant was taken, resuspended pellet was gently blown and spread onto LB medium containing the corresponding antibiotic (concentrations were 50 mg/L). The plates were placed in an incubator at 28℃overnight.
And adopting an agrobacterium infection cotyledonary node method to perform soybean stable transformation. The acceptor variety used for soybean stable genetic transformation is Ji 602 in northeast variety, and the resistance is glyphosate. The specific process is as follows: placing the chlorine sterilized Zhongji 602 seeds in a culture dish, taking cotyledonary nodes as explants after germination to carry out agrobacterium infection, and carrying out processes of induction culture, elongation culture, rooting culture and the like on the explants to obtain 103 plants stably transformed in the T0 generation.
EXAMPLE 3 Multi-Gene editing mutant screening
Screening positive plants, identifying sgRNA distribution conditions and detecting targeted gene editing conditions of the soybean plants obtained in the example 2, taking seeds harvested from T0 generation five-site heterozygous editing plants, and planting the seeds in a growing chamber by potting to obtain T1 generation plants. Extracting DNA from leaves of T1 generation plants by using a CTAB method, and carrying out PCR amplification by using primers SEQ ID 11-SEQ ID 20, wherein a PCR reaction system (25 μl): 1 μl of template; KOD One PCR Master Mix 12.5.5 μl; 0.5. Mu.l each of the upstream and downstream primers; 10.5 μl of deionized water. PCR reaction procedure: pre-denaturation at 95℃for 3min; denaturation at 95 ℃ for 30s, annealing at 58 ℃ for 30s, extension at 72 ℃ for 1min, and 34 cycles of denaturation, annealing and extension are performed; finally, the extension is carried out for 3min at 72 ℃. 1.5 μl of the amplified product was pipetted for identifying the amplification result by agarose gel electrophoresis, the electrophoresis result is shown in FIG. 3, wherein lane 1 is a positive control and lane 2 is soybean. And (3) carrying out Sanger sequencing on the rest products to detect five gene editing conditions, so as to obtain a homozygous editing material Y1, wherein the DNA sequencing result of the editing material Y1 in a target site area is shown in fig. 4, wherein A is a GmLOX1 site sequencing result, B is a GmLOX2 site sequencing result, C is a GmLOX3 site sequencing result, D is a GmFAD2-1A site sequencing result, and E is a GmFAD2-1B site sequencing result. And (3) counting 103 soybean gene editing conditions, and displaying the results: at least one target site of 72T 0 positive transgenic plants in 103T 0 positive seedlings is mutated, wherein the editing efficiency of the target site of GmLOX1 is 47%, the editing efficiency of the target site of GmLOX2 is 47%, the editing efficiency of the target site of GmLOX3 is only 7%, the editing efficiency of the target site of GmFAD2-1A is 46%, and the editing efficiency of the target site of GmFAD2-1B is 45%.
EXAMPLE 4 homozygous editing Material Y1 qualification
1. Lipoxygenase assay
Seeds harvested at maturity after the editing material Y1 planting were used to determine LOX enzyme activity. LOX enzyme activity is measured by colorimetric assayThe flow is as follows: 1) The dried seed samples were separately ground to a powder. 2) Seed sample powders 15, 30 and 15mg were weighed respectively, and 0.2mol/L in 1.5mL each -1 Sodium borate buffer (pH 9.0), 1.5mL of 0.2mol L -1 Sodium phosphate buffer (pH 6.0) and 1.5mL of 0.2mol/L -1 Lipoxygenase solutions 1, 2 and 3 (designated LS1, LS2 and LS3 for detection of LOX1, LOX2, LOX3, respectively) were extracted in sodium phosphate buffer (pH 6.6), and were subjected to stationary extraction at 4℃for 1 hour, followed by centrifugation (12000 rpm,5min,4 ℃) to obtain supernatants. 3) Detection of LOX1 enzyme activity: 0.5mL of LS1 was added to 1.0mL of substrate solution 1 (containing 0.125mol/L sodium borate buffer at pH 9.0) -1 Methylene blue 12.5. Mu. Mol/L -1 1.375mmol/L sodium linoleate substrate -1 ). Detection of LOX2 enzyme activity: 0.5mL of LS2 was added to 1.0mL of substrate solution 2 (containing 0.125mol/L sodium phosphate buffer solution at pH 6.0) -1 Methylene blue 12.5. Mu. Mol/L -1 1.375mmol/L sodium linoleate substrate -1 Dithiothreitol 25mmol/L -1 Acetone 12.5%). Detection of LOX3 enzyme activity: 0.5mL of LS3 was added to 1.0mL of substrate solution 3 (containing 0.125mol/L sodium phosphate buffer solution at pH 6.6) -1 1.375mmol/L sodium linoleate substrate -1 12.5% of beta-carotene substrate). After mixing, each reaction was incubated in a clear centrifuge tube for 15min and the solution color was recorded (LOX 1 and LOX2 are colorless or blue, and LOX3 is colorless or yellow). 4) At 660nm (for measuring LOX1 and LOX 2) and 452nm (for measuring LOX 3), the measurement was performed with a spectrophotometer (UV-1600; shimadzu, kyoto, japan) to determine the absorbance of each sample.
The results of the measurements are shown in FIGS. 5 to 7, wherein FIG. 5 shows the results of the measurement of the LOX1 enzyme activity of the editing material, CK (water) represents ultrapure water, ZJ602 represents Zhongji 602 having the LOX1 enzyme activity, WT is colorless, and CK (water) and Y1 show blue, indicating that Y1 does not contain the LOX1 enzyme activity. FIG. 6 is a graph showing the results of measuring the activity of LOX2 enzyme of the editing material, CK (water) represents ultrapure water, ZJ602 represents Zhongji 602 having the activity of LOX1 enzyme, WT is colorless, and CK (water) and Y1 show blue colors, indicating that Y1 does not contain the activity of LOX2 enzyme. FIG. 7 is a graph showing the results of measuring the activity of LOX3 enzyme of the editing material, CK represents ultrapure water, ZJ602 represents Zhongji 602 having the activity of LOX1 enzyme, WT is colorless, and CK (water) and Y1 show yellow color, indicating that Y1 does not contain the activity of LOX2 enzyme. As is clear from FIGS. 5 to 7, the homozygously edited material Y1 was a full deletion mutant, and did not contain LOX enzyme activity.
SDS-PAGE electrophoresis Lox isozymes identification
1) Sample treatment:
weighing 3mg of the seed powder, placing into a 2mL centrifuge tube, adding 300 mu L of protein extract, stirring uniformly by using a vibrator, centrifuging for 5min at 12000r/min, and taking 10 mu L for SDS-PAGE electrophoresis analysis.
2) Preparing polyacrylamide gel:
and (3) solution A: SDS 2.0g, tris 181.2g, 1 mol.L -1 HCl adjusts pH to 8.8, and finally distilled water is added to fix volume to 500mL.
And C, liquid: acylamide 30g, bisacrylamide 0.8g and distilled water to a volume of 100mL.
And (3) P solution: 1.5g of ammonium persulfate, and distilled water was added to 100mL.
And (2) liquid B: SDS 4g, tris 15g, distilled water to 500mL.
E, liquid: riboflavin 4mg, 100mL of distilled water was added and mixed well.
3) Preparation of the reaction solution
The aglycone 14.4g,Tris 3.0g,SDS 1.25g is added with 1000mL distilled water and evenly mixed to prepare the electrophoresis buffer solution. And (5) adding 440mL of ethanol (analytical alcohol) and 60mL of acetic acid into Ma Si brilliant blue R-2501.5g, and adding distilled water to 1000mL to prepare a staining solution. 200mL of methanol and 50mL of acetic acid are measured by a measuring cylinder, distilled water is added to 1000mL, and the mixture is uniformly mixed to prepare decolorized solution.
4) Assembly of glass sheets
The method comprises the steps of preparing a glass plate for common SDS-PAGE with the glue thickness of 1mm, wiping the inner surface of the glass plate with 70% ethanol, airing, placing sealing silica gel strips (or silica gel tubes) for glue leakage prevention, fixing 2 plates on the left side and the right side of the glass plate respectively by using 4 large-size long tail clips, and vertically placing the glass plate on a horizontal experiment table.
5) Preparation of separation gel
Taking 1 piece of glue with the specification of 10cm multiplied by 8cm multiplied by 1mm as an example, 6.75% of polyacrylamide gel liquid, namely adding 1.25mL of A liquid, 1.13mL of C liquid and 0.25mL of P liquid into a10 mL centrifuge tube according to the sequence of 2.38mL of distilled water, fully and uniformly mixing, adding TEMED 4uL, uniformly mixing, uniformly pouring into a gap of a glass plate, slightly dripping a proper amount of distilled water at the upper part of the glue surface to prevent the glue surface from drying, standing at room temperature for 20-30 min for solidification, pouring out the upper distilled water, standing upside down on a table top, and removing residual water for standby.
6) Preparation of concentrated gel
1.07mL of liquid B, 0.33mL of liquid C, 0.43mL of liquid E and 0.07mL of liquid P are sequentially added according to the following sequence, after the mixture is fully and uniformly mixed with 0.10mL of distilled water, TEMED 2uL is added and uniformly mixed, the mixture is evenly poured into the upper layer of the separation gel, a comb is inserted, and the mixture is placed at room temperature for 20 to 30 minutes. After the gel is solidified, the fixing clamp is removed, the incomplete solidified residual gel is gently washed by distilled water, and the residual gel is wrapped by a preservative film and is inverted and refrigerated at 4 ℃ for standby.
7) SDS-PAGE electrophoresis
From the result of electrophoresis, the deletion state of the Lox isozymes was confirmed, and as shown in fig. 8, it was found from fig. 8 that all three Lox isozymes in the editing material Y1 were deleted.
3. Fatty acid content detection
The Y1 material is planted and then harvested to obtain a T2 generation seed, the T2 generation seed is subjected to fatty acid content detection, a first internal standard method of national standard GB5009.168-2016 is adopted, a gas chromatography method is used for five fatty acid determination of a receptor material and a transgenic editing material, the result is shown in figure 9, and the oleic acid content of the editing material Y1 is improved to more than 80% as can be seen from figure 9.
Example 5 identification of editing Material Using molecular markers
Electrophoresis verification was performed on GmLOX1, gmLOX2 site and GmLOX3 site, respectively.
1.GmLOX1, gmLOX3 site verification
The site electrophoresis verification of GmLOX1 and GmLOX3 is carried out by using 6% polyacrylamide gel electrophoresis, the PCR amplification reaction is carried out by using the extracted soybean seed DNA as a template, a molecular marker as a primer and using Easy Taq enzyme, the reaction system is 20 mu L, the template is diluted to 20ng 2 mu L, the concentration of the upstream primer and the downstream primer is 2 mu L respectively (2 mu M), the Easy Taq enzyme is 0.5 mu L, dNTP is 1.5 mu L and buffer is 2 mu L. The primers used for verifying the GmLOX1 locus are shown in SEQ ID NO. 5-SEQ ID NO.6, and the primers used for verifying the GmLOX3 locus are shown in SEQ ID NO. 7-SEQ ID NO. 8. The reaction procedure: pre-denaturing at 95 ℃ for 5min, denaturing at 95 ℃ for 30s, annealing at 55 ℃ for 30s, extending at 72 ℃ for 30s, performing denaturation, annealing and extension for 25 cycles, preserving at 4 ℃ finally, and separating the amplified product by using 6% denatured polypropylene gel electrophoresis.
2.GmLOX2 site verification
The method comprises the steps of identifying GmLOX2 sites by agarose gel electrophoresis, weighing 0.4g of agar, correspondingly adding 40mL of 1xTAE solution, dissolving for 2min by a microwave oven, cleaning a gel groove in the process of dissolving the agar by the microwave oven, putting into a gel manufacturing plate, then inserting a comb with a proper aperture into a fixed clamping groove of the gel groove, after the agar is fully melted, cooling to 50-60 ℃ in water at too high temperature, adding EB (ethidium bromide) or TB Green dye, fully and uniformly mixing, pouring the agar solution gently along one side of the gel manufacturing plate to avoid generating bubbles, but also avoiding long agar solidification, and after the agar is solidified for about 20min, vertically and slowly pulling out the comb to avoid damaging gel holes. After agarose gel preparation is completed, placing the agarose gel into an electrophoresis tank for electrophoresis, pouring 1xTAE electrophoresis solution during electrophoresis, immersing the gel, sequentially adding samples (after bromophenol blue is added) into sample application holes by using a10 uL pipetting gun, turning on a power supply of an electrophoresis apparatus, setting voltage to 140V, finishing after electrophoresis for 25min, and comparing the sizes of the strips according to the gel.
As shown in FIG. 10, the size of the GmLOX1 locus product is 145bp, and the size of the editing material product is 143bp as shown in FIG. 10; the size of the GmLOX2 locus product is 162bp, and the size of the editing material product is 103bp; the size of the GmLOX3 locus product is 92bp, and the size of the editing material product is 96bp.
The electrophoresis verification is performed similarly for the GmFAD2-1A site and the GmFAD2-1B site, and the experimental procedure is the same as that for the verification of the GmLOX1 and GmLOX3 sites.
From the above examples, the present invention provides a method for constructing sgRNA combinations of new soybean varieties and cultivating new soybean varieties and application thereof, which can obtain soybean editing materials with high oleic acid content and low lipoxygenase content, and provides valuable genetic resources, germplasm resources and resource identification methods for soybean breeding.
The foregoing is merely a preferred embodiment of the present invention and it should be noted that modifications and adaptations to those skilled in the art may be made without departing from the principles of the present invention, which are intended to be comprehended within the scope of the present invention.
Claims (9)
1. The sgRNA combination for constructing the new soybean variety is characterized by comprising sgRN A-GmLOX1, sgRNA-GmLOX2, sgRNA-GmLOX3 and sgRNA-GmFAD2-1A/B, wherein the sequence of the sgRNA-GmLOX1 is shown as SEQ ID NO.1, the sequence of the sgRNA-GmL OX2 is shown as SEQ ID NO.2, the sequence of the sgRNA-GmLOX3 is shown as SEQ ID NO.3, and the sequence of the sgRNA-GmFAD2-1A/B is shown as SEQ ID NO. 4.
2. An expression vector combination for CRISPR/Cas9 editing, which is characterized by comprising a first expression vector and a second expression vector;
the first expression vector is obtained by cloning the sgRNA-GmLOX1, sgRNA-GmLOX2, sgRNA-GmLOX3 of claim 1 onto the initial expression vector pBSE 401; the second expression vector was obtained by cloning sgRNA-GmFAD2-1A/B onto the initial expression vector pBSE 401.
3. A method for constructing a new soybean variety by using CRISPR/Cas9 technology, which is characterized by comprising the following steps:
the first expression vector and the second expression vector of claim 2 are transformed into agrobacterium, soybeans are infected by using agrobacterium, and new soybean varieties with deleted genes of GmLOX1, gmLOX2, gmLOX3, gmFAD2-1A and GmFAD2-1B are obtained by screening.
4. A method according to claim 3, wherein the agrobacterium comprises agrobacterium EHA105.
5. A method according to claim 3, wherein the locus of the infested soybean is a cotyledonary node of soybean.
6. The method of claim 3, wherein the screening method comprises kanamycin resistance screening and positive plant PCR amplification and sequencing.
7. Use of the sgRNA combination of claim 1, the CRISPR/Cas9 editing expression vector combination of claim 2 or the method of any one of claims 3 to 6 for breeding high oleic acid soybean germplasm.
8. Use of the sgRNA combination of claim 1, the CRISPR/Cas9 editing expression vector combination of claim 2, or the method of any one of claims 3 to 6 for cultivating beany-free soybean germplasm.
9. A primer set for identifying a new soybean variety of claim 3, comprising primers for detecting GmLOX1 site, gmLOX2 site and GmLOX3 site;
the upstream and downstream primer sequences of the GmLOX1 locus are shown in SEQ ID NO.5 and SEQ ID NO. 6;
the upstream and downstream primer sequences for detecting the GmLOX2 locus are shown in SEQ ID NO.7 and SEQ ID NO. 8;
the upstream and downstream primer sequences for detecting the GmLOX3 locus are shown as SEQ ID NO.9 and SEQ ID NO. 10.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310504665.5A CN116555263A (en) | 2023-05-06 | 2023-05-06 | Method for constructing sgRNA combination of new soybean variety and cultivating new soybean variety and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310504665.5A CN116555263A (en) | 2023-05-06 | 2023-05-06 | Method for constructing sgRNA combination of new soybean variety and cultivating new soybean variety and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116555263A true CN116555263A (en) | 2023-08-08 |
Family
ID=87502987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310504665.5A Pending CN116555263A (en) | 2023-05-06 | 2023-05-06 | Method for constructing sgRNA combination of new soybean variety and cultivating new soybean variety and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116555263A (en) |
-
2023
- 2023-05-06 CN CN202310504665.5A patent/CN116555263A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110257421B (en) | Construction method and application of brassica napus gene mutant PTG8 | |
CN110684796B (en) | Method for specifically knocking out soybean lipoxygenase gene by CRISPR-Cas9 and application thereof | |
US10077450B2 (en) | Sugarcane bacilliform viral (SCBV) enhancer and its use in plant functional genomics | |
CN109486853A (en) | A method of quickly formulating the engineering Female sterile clone for being suitble to the mechanization production of hybrid seeds using genome editing technique | |
CN112501187A (en) | Method for obtaining high-oleic-acid soybeans by modifying GmFAD2-1A and GmFAD2-1B through simultaneous gene editing | |
CN106701784B (en) | Soybean oil body protein gene GmOLEO1, and coding protein and application thereof | |
US20050262591A1 (en) | Fatty acid desaturases and mutant sequences thereof | |
CN110438146A (en) | A method of obtaining the rape variety of the low sulphur resources of seed | |
CN112048515B (en) | Rape S-adenosine-L-methionine dependent methyltransferase gene BnPMT6 and application thereof | |
CN101550414A (en) | Method for obtaining cole with high oleic acid and low erucic acid by dual-approach gene expression synchronous suppression | |
CN116769796B (en) | ZmENR1 and application of coded protein thereof in corn fertility control | |
CN103739686A (en) | Protein related to plant yield improvement and quality improvement, and encoding gene and application thereof | |
CN116555263A (en) | Method for constructing sgRNA combination of new soybean variety and cultivating new soybean variety and application | |
CN112538481B (en) | Method for obtaining high oleic acid plants by using gene editing technology | |
CN110982838B (en) | Method for changing rape seed fatty acid composition by using gene editing technology and application thereof | |
CN112592934A (en) | Method for obtaining soybean with high oleic acid content by modifying GmFAD2-1A gene through CRISPR/Cas9 | |
Arifin et al. | Asparaginyl-tRNA synthetase gene (SYNC1) characterized by Lotus corniculatus FOX-superroot lines has effects on plant morphology and amino acid contents of seed in soybean | |
CN110982816B (en) | Method for obtaining high-stearic acid rape | |
CN115094084B (en) | Application of rice OsRS gene in breeding high-seed-activity rice | |
CN109971765A (en) | A kind of corn gene ZmNAC77 and its application of regulation arabidopsis fatty acid and content of starch | |
CN112391408B (en) | Method for breeding high-carotenoid rape seeds by using gene editing technology | |
CN116926107A (en) | Method for specifically knocking out soybean lipoxygenase gene by CRISPR-Cas9 and application | |
CN116837002B (en) | Application of ZmDPP1 and coded protein thereof in corn fertility control | |
CN117247967B (en) | Male sterile gene ZmPKSA and application thereof in creating maize male sterile line | |
CN113667731B (en) | Method for rapidly identifying and regulating rape oil content gene based on genomics approach and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |